These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 1588829)
1. A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition. Bard JM; Parra HJ; Camare R; Luc G; Ziegler O; Dachet C; Bruckert E; Douste-Blazy P; Drouin P; Jacotot B Metabolism; 1992 May; 41(5):498-503. PubMed ID: 1588829 [TBL] [Abstract][Full Text] [Related]
3. Effects of simvastatin and fenofibrate on serum lipoproteins and apolipoproteins in primary hypercholesterolaemia. Stohler R; Keller U; Riesen WF Eur J Clin Pharmacol; 1989; 37(2):199-203. PubMed ID: 2507323 [TBL] [Abstract][Full Text] [Related]
4. Safety, tolerability, and efficacy of simvastatin and fenofibrate--a multicenter study. Simvastatin-Fenofibrate Study Group. Ziegler O; Drouin P Cardiology; 1990; 77 Suppl 4():50-7. PubMed ID: 2073672 [TBL] [Abstract][Full Text] [Related]
5. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia]. Riesen WF; Keller U; Del Bufalo A; Reutter FW; Baur HR; Golay A; Bertel O; Kummer H; Kistler H; Ammann F Schweiz Med Wochenschr; 1989 Dec; 119(48):1719-23. PubMed ID: 2694363 [TBL] [Abstract][Full Text] [Related]
6. [The efficacy and tolerance of simvastatin and fenofibrate in primary hypercholesterolemia]. Fricker J; Douste-Blazy P; Drouin P; De Gennes JL; Dachet C; Keller U Presse Med; 1990 Dec; 19(42):1927-30. PubMed ID: 2147752 [TBL] [Abstract][Full Text] [Related]
7. Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia. Bard JM; Luc G; Douste-Blazy P; Drouin P; Ziegler O; Jacotot B; Dachet C; De Gennes JL; Fruchart JC Eur J Clin Pharmacol; 1989; 37(6):545-50. PubMed ID: 2693115 [TBL] [Abstract][Full Text] [Related]
8. Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia. Steinmetz A; Schwartz T; Hehnke U; Kaffarnik H J Cardiovasc Pharmacol; 1996 Apr; 27(4):563-70. PubMed ID: 8847874 [TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia. Farnier M; Bonnefous F; Debbas N; Irvine A Arch Intern Med; 1994 Feb; 154(4):441-9. PubMed ID: 8117177 [TBL] [Abstract][Full Text] [Related]
10. Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition. Bard JM; Parra HJ; Douste-Blazy P; Fruchart JC Metabolism; 1990 Mar; 39(3):269-73. PubMed ID: 2106607 [TBL] [Abstract][Full Text] [Related]
11. Effects of gemfibrozil or simvastatin on apolipoprotein-B-containing lipoproteins, apolipoprotein-CIII and lipoprotein(a) in familial combined hyperlipidaemia. Bredie SJ; Westerveld HT; Knipscheer HC; de Bruin TW; Kastelein JJ; Stalenhoef AF Neth J Med; 1996 Aug; 49(2):59-67. PubMed ID: 8824106 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia. Bruckert E; De Gennes JL; Malbecq W; Baigts F Clin Cardiol; 1995 Nov; 18(11):621-9. PubMed ID: 8590530 [TBL] [Abstract][Full Text] [Related]
13. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia. Saku K; Sasaki J; Arakawa K Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571 [TBL] [Abstract][Full Text] [Related]
14. Influence of simvastatin, fenofibrate and/or ezetimibe on correlation of low-density lipoprotein and nonhigh-density lipoprotein cholesterol with apolipoprotein B in mixed dyslipidemic patients. Farnier M; Taggart W; Dong Q; Lin J; Shah A; Brudi P J Clin Lipidol; 2011; 5(3):179-187. PubMed ID: 21600523 [TBL] [Abstract][Full Text] [Related]
15. Effect of fenofibrate treatment on plasma lipoprotein lipids, high-density lipoprotein cholesterol subfractions, and apolipoproteins B, AI, AII, and E. Knopp RH; Walden CE; Warnick GR; Albers JJ; Ginsberg J; McGinnis BM Am J Med; 1987 Nov; 83(5B):75-84. PubMed ID: 3120587 [TBL] [Abstract][Full Text] [Related]
16. [Effects of simvastatin on blood levels of lipoprotein (a)]. Galetta F; Sampietro T; Basta G; Giannasi G; Bionda A Minerva Med; 1995; 86(7-8):299-303. PubMed ID: 7478073 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia. Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392 [TBL] [Abstract][Full Text] [Related]
19. Effect of simvastatin on high density lipoprotein subfractions and apolipoproteins in type IIa hypercholesterolemia. Crook D; Bruce R; Worthington M; Mulcahy D; Patterson D; Wynn V Cardiovasc Drugs Ther; 1992 Dec; 6(6):633-9. PubMed ID: 1292582 [TBL] [Abstract][Full Text] [Related]
20. [Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia]. Caruzzo C; Uslenghi E; Varbella F; Caruzzo E; Marcolongo M; Brusca A Minerva Cardioangiol; 1989 Dec; 37(12):509-15. PubMed ID: 2695857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]